- Home
- QURE vs SCZM Comparison
QURE vs SCZM Comparison
Compare QURE & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | SCZM |
|---|---|---|
| Founded | 1998 | N/A |
| Country | Netherlands | Canada |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | QURE | SCZM |
|---|---|---|
| Price | $19.16 | $8.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $45.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 416.3K |
| Earning Date | 05-05-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $79.38 |
| Revenue Next Year | $200.43 | N/A |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $6.90 |
| 52 Week High | $71.50 | $17.65 |
Technical Indicators
Market Signals| Indicator | QURE | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 45.13 |
| Support Level | $13.46 | $6.90 |
| Resistance Level | $25.66 | $9.05 |
| Average True Range (ATR) | 1.26 | 0.50 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 64.47 | 29.53 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.